Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses PAC Q1 2026 Earnings Strong EPS Beat Fails to Lift Stock Amid Cautious Sentiment Atmus Filtration Technologies Q1 2026 Earnings EPS Beat Drives Positive Momentum Runway Growth Finance Corp Q1 2026 Earnings EPS Misses Estimates Amid Stable Portfolio Performance AGM Q1 2026 Earnings Strong EPS Beat Driven by Core Operations ARM Q1 2026 Earnings EPS Beats Estimates Amid Strong Licensing Demand